11.1 Anesthesia Modalities, Phases, and Emergency Complications

11.1 Anesthesia Modalities, Phases, and Emergency Complications

Anesthesia is the reversible pharmacological induction of a state characterized by loss of sensation, analgesia, hypnosis (amnesia and unconsciousness), autonomic reflex suppression, and skeletal muscle relaxation. In the operating room, modern perioperative medicine requires seamless collaboration between the anesthesia care team (anesthesiologists and certified registered nurse anesthetists [CRNAs]) and surgical team members.

For the Tech in Surgery - Certified (NCCT TS-C) examination, mastery of anesthesia principles supports the Perioperative Care Basic Science task area (uses, effects, and complications of drugs; appropriate fluids) and the Essential Knowledge Base pharmacology concept. The certified surgical technologist (CST) must thoroughly understand the distinct anesthesia modalities, the four physiological phases of general anesthesia, airway management devices, conduction blocks, and the immediate protocols for life-threatening intraoperative crises such as Malignant Hyperthermia (MH) and Local Anesthetic Systemic Toxicity (LAST).

---

1. Classification of Anesthesia Modalities

Anesthetic delivery is categorized into distinct modalities based on the anatomical target, depth of central nervous system (CNS) depression, and preservation of protective airway reflexes.

+-----------------------------------------------------------------------------+
|                        SPECTRUM OF ANESTHETIC MODALITIES                    |
|                                                                             |
|   [LOCAL / TOPICAL]    -> Direct sensory nerve blockade in target tissue    |
|   [REGIONAL CONDUCTION]-> Axonal conduction block of nerve plexuses/spinal  |
|   [MONITORED CARE/MAC] -> Sedation, analgesia, amnesia; patent airway       |
|   [GENERAL ANESTHESIA] -> Reversible total CNS depression, muscle paralysis |
+-----------------------------------------------------------------------------+

Modality Comparison Matrix

---

2. General Anesthesia: Guedel's Stages and Perioperative Phases

General anesthesia achieves five primary clinical endpoints: hypnosis (unconsciousness), amnesia (loss of memory), analgesia (loss of pain sensation), areflexia (loss of autonomic and somatic motor reflexes), and muscle relaxation.

Guedel's Classic Stages of Ether Anesthesia

Originally described by Dr. Arthur Guedel for inhalational diethyl ether, these four classic stages delineate the progression of CNS depression:

1. Stage I (Amnesia / Induction Stage): Extends from initial administration of anesthetic agents to the loss of consciousness. The patient experiences analgesia, drowsiness, and altered sensory perception, but reflexes remain intact.
2. Stage II (Excitement / Delirium Stage): Extends from loss of consciousness to the onset of regular, automatic respiration. Characterized by uninhibited CNS activity: irregular breathing, involuntary motor struggling, breath-holding, dilated pupils that react to light, active swallowing, vomiting, and extreme susceptibility to laryngospasm and cardiac arrhythmias triggered by auditory or physical stimulation. CST Rule: Maintain absolute silence, avoid touching or moving the patient, and have functional suction ready.
3. Stage III (Surgical Anesthesia Stage): Extends from the onset of regular breathing to the cessation of spontaneous respiration. Characterized by loss of the eyelid reflex, pupil constriction, regular diaphragmatic/intercostal breathing, and skeletal muscle relaxation. This is the optimal plane for surgical incision and dissection.
4. Stage IV (Medullary Depression / Overdose Stage): Severe CNS depression extending from respiratory arrest to circulatory collapse and death. Occurs when anesthetic depth paralyzes the vasomotor and respiratory control centers of the medulla oblongata. Requires immediate cessation of anesthetic agents, reversal drugs, 100% oxygen ventilation, and cardiopulmonary resuscitation.

+-----------------------------------------------------------------------------+
|                   FOUR CLINICAL PHASES OF GENERAL ANESTHESIA                |
|                                                                             |
|   [1. INDUCTION]    -> Administration of IV/Gas agents; secure airway (ETT) |
|   [2. MAINTENANCE]  -> Sustained surgical depth during operative procedure  |
|   [3. EMERGENCE]    -> Discontinuation of agents, reversal, extubation      |
|   [4. RECOVERY]     -> PACU monitoring, airway stabilization, pain control  |
+-----------------------------------------------------------------------------+

The Four Clinical Phases and CST Responsibilities

1. Induction Phase

• Description: Transition from an awake, conscious state to surgical anesthesia. Initiated with IV induction agents (e.g., Propofol, Etomidate, Ketamine) followed by short-acting neuromuscular blocking agents (e.g., Succinylcholine or Rocuronium) to facilitate tracheal intubation.
• Airway Securing: An endotracheal tube (ETT) or laryngeal mask airway (LMA) is inserted and verified via bilateral chest auscultation and capnography (EtCO2).
• Rapid Sequence Induction (RSI): Indicated in patients with a "full stomach" (unfasted trauma, bowel obstruction, gastroesophageal reflux, pregnancy) to prevent pulmonary aspiration of acidic gastric contents. The anesthesia provider performs cricoid pressure (Sellick's maneuver): downward posterior compression of the rigid cricoid cartilage (10–30 N force) against the sixth cervical vertebra (C6) to completely occlude the esophagus until the ETT cuff is inflated and position verified.
• CST Duties: Absolute silence in the room; no movement of equipment or patient; stand by the sterile back table; remain prepared to assist anesthesia if requested; have emergency suction connected and operational.

2. Maintenance Phase

• Description: Sustaining the desired depth of surgical anesthesia, hemodynamic stability, muscle relaxation, and analgesia throughout the operative intervention. Combines volatile halogenated inhalation agents (Sevoflurane, Desflurane, Isoflurane) with balanced IV infusions (opioids such as Fentanyl, Sufentanil; paralytics such as Vecuronium, Cisatracurium).
• CST Duties: Active intraoperative scrubbing, maintaining the sterile field, anticipating surgeon instrument needs, monitoring fluid/irrigation volumes, tracking blood loss on lap sponges, and communicating with the circulator.

3. Emergence Phase

• Description: The process of awakening the patient as the surgical procedure concludes. Anesthetic vapors are turned off; residual neuromuscular blockade is pharmacologically reversed (e.g., Neostigmine/Glycopyrrolate or Sugammadex); spontaneous respiration returns; the trachea is suctioned; and extubation is performed once protective airway reflexes (swallowing, coughing, gagging) return.
• Hazards: High risk for laryngospasm, severe coughing (bucking on the ETT), hypertension, tachycardia, vomiting, and emergence delirium.
• CST Duties: Maintain sterile field integrity until the patient is extubated and safely transported out of the room; remain quiet during extubation; preserve sterile drapes until the dressing is secured; hold suction ready for anesthesia.

4. Recovery Phase (PACU Phase I & II)

• Description: Postoperative emergence monitoring in the Post-Anesthesia Care Unit (PACU) until physiological parameters stabilize. Vital signs, oxygenation, pain, surgical site bleeding, and level of consciousness are evaluated using standardized criteria (e.g., the Aldrete Score, requiring 8 to 10 points for discharge).

---

3. Airway Management Instrumentation and Intubation Modalities

Maintaining a patent airway and ensuring continuous pulmonary gas exchange is paramount under general anesthesia.

+-----------------------------------------------------------------------------+
|                        AIRWAY MANAGEMENT ARSENAL                            |
|                                                                             |
|   DIRECT LARYNGOSCOPY   -> Macintosh (curved) / Miller (straight) blades   |
|   VIDEO LARYNGOSCOPY    -> GlideScope, McGrath (camera view of glottis)     |
|   SUPRAGLOTTIC AIRWAYS  -> Laryngeal Mask Airway (LMA), King LT, i-gel      |
|   ENDOTRACHEAL TUBES    -> Cuffed (Murphy eye) vs. Uncuffed (pediatric)     |
|   SURGICAL AIRWAYS      -> Cricothyroidotomy (emergency) / Tracheostomy     |
+-----------------------------------------------------------------------------+

Airway Devices and Clinical Application

• Endotracheal Tube (ETT): Flexible polyvinyl chloride (PVC) tube placed directly through the vocal cords into the trachea (seated 2–3 cm above the carina). Features an inflatable distal cuff (monitored between 20–30 cm H2O pressure) to prevent aspiration and gas leakage, a radio-opaque marker line, and a Murphy eye (side hole providing ventilation if the primary distal bevel becomes occluded by the tracheal wall).
• Supraglottic Airway Devices (e.g., LMA): Positioned in the hypopharynx resting over the laryngeal inlet without penetrating the vocal cords. Ideal for short, low-risk procedures without muscle relaxation; contraindicated in unfasted patients or high-pressure positive ventilation due to gastric insufflation risk.
• Laryngoscope Blades:
  • Macintosh Blade: Curved blade whose distal tip is inserted into the vallecula (the anatomical space between the base of the tongue and the epiglottis) to indirectly elevate the epiglottis and expose the glottic opening.
  • Miller Blade: Straight blade whose distal tip directly lifts the underside of the epiglottis upward to expose the vocal cords (commonly preferred in pediatric infants and patients with floppy epiglottides).
• Magill Forceps: Angled sterile forceps used to grasp and guide the tip of the endotracheal tube into the laryngeal aperture during difficult intubation or to place nasogastric (NG) tubes.
• Emergency Surgical Airway:
  • Needle/Surgical Cricothyroidotomy: Rapid emergency incision through the cricothyroid membrane between the thyroid and cricoid cartilages for the catastrophic "cannot intubate, cannot ventilate" scenario.
  • Tracheostomy: Controlled surgical creation of an opening into the 2nd–4th tracheal rings for long-term mechanical ventilation or extensive maxillofacial trauma.

---

4. Regional and Conduction Anesthesia

Regional anesthesia blocks neural impulse transmission along targeted nerve trunks, producing dense surgical analgesia and motor blockade without altering systemic consciousness.

+-----------------------------------------------------------------------------+
|                  SPINAL VS. EPIDURAL ANATOMICAL COMPARISON                  |
|                                                                             |
|   SKIN & SUBCUTANEOUS TISSUE                                                |
|       |                                                                     |
|   SUPRASPINOUS LIGAMENT                                                     |
|       |                                                                     |
|   INTERSPINOUS LIGAMENT                                                     |
|       |                                                                     |
|   LIGAMENTUM FLAVUM (Dense, yellow elastic resistance - "Pop")              |
|       |                                                                     |
|   [EPIDURAL SPACE]  =====> (Potential space: Fat, Batson's venous plexus)   |
|       |                    *EPIDURAL BLOCK TARGET (L1-L5 / Thoracic)*       |
|   DURA MATER & ARACHNOID                                                    |
|       |                                                                     |
|   [SUBARACHNOID SPACE] ==> (Contains CSF: Clear, pressurized fluid)         |
|                            *SPINAL BLOCK TARGET (L3-L4 or L4-L5 only)*      |
|   PIA MATER & SPINAL CORD (Terminates at Conus Medullaris: L1-L2 adult)     |
+-----------------------------------------------------------------------------+

1. Spinal (Subarachnoid) Anesthesia

• Anatomical Target: The local anesthetic (e.g., hyperbaric 0.75% Bupivacaine in dextrose) is injected directly into the subarachnoid space mixing with cerebrospinal fluid (CSF).
• Needle Insertion Level: Performed strictly below the termination of the spinal cord (conus medullaris, which ends at L1–L2 in adults), typically at the L3–L4 or L4–L5 intervertebral space, utilizing a fine-gauge pencil-point needle (e.g., 25-gauge or 27-gauge Whitacre or Sprotte) to minimize dural trauma.
• Complications:
  • Post-Dural Puncture Headache (PDPH): Caused by persistent CSF leakage through the dural hole, resulting in traction on meningeal pain fibers when upright. Managed with recumbent bed rest, hydration, caffeine, and definitive autologous epidural blood patch (15–20 mL of patient's sterile venous blood injected into the epidural space to clot over the dural defect).
  • High / Total Spinal: Local anesthetic spreads cephalad, causing severe hypotension, bradycardia, intercostal/diaphragmatic paralysis (C3–C5 phrenic nerve blockade), and loss of consciousness, requiring immediate intubation and vasopressors.

2. Epidural Anesthesia

• Anatomical Target: Local anesthetic is deposited into the epidural space between the ligamentum flavum and the dura mater. Identified using the loss-of-resistance (LOR) technique with saline or air via a specialized curved-tip Tuohy needle.
• Flexibility: A fine polyethylene epidural catheter can be threaded into the space, allowing continuous infusions for prolonged operative cases and multiday postoperative patient-controlled epidural analgesia (PCEA).

3. Intravenous Regional Anesthesia (Bier Block)

• Procedure: Indicated for quick upper extremity procedures (<60 minutes). A peripheral IV is placed in the surgical hand -> limb is exsanguinated from distal to proximal using a tightly wrapped rubber Esmarch bandage -> a dual-cuffed pneumatic tourniquet on the upper arm is inflated to 250 mmHg (or 100 mmHg above systolic BP) -> preservative-free 0.5% Lidocaine plain (30–50 mL) is injected IV into the isolated limb, rapidly diffusing into capillary beds and nerve endings.
• Critical Safety Mandates:
  • Never use Bupivacaine (Marcaine): Highly cardiotoxic; accidental systemic release causes fatal refractory ventricular arrhythmias.
  • Minimum Tourniquet Time: The tourniquet must remain inflated for at least 20 minutes (even if the surgery lasts only 10 minutes) to allow sufficient tissue binding and prevent a massive, lethal systemic bolus of local anesthetic upon deflation.

---

5. Life-Threatening Anesthesia Emergencies and CST Action Protocols

1. Malignant Hyperthermia (MH)

[!CAUTION] Malignant Hyperthermia (MH): An acute, life-threatening pharmacogenetic hypermetabolic crisis of skeletal muscle triggered in genetically susceptible individuals possessing an autosomal dominant mutation in the Ryanodine receptor type 1 (RYR1) or voltage-gated calcium channel alpha-1S subunit (CACNA1S) gene.

+-----------------------------------------------------------------------------+
|                        MALIGNANT HYPERTHERMIA CASCADE                       |
|                                                                             |
|   TRIGGERING AGENTS (Succinylcholine / Halogenated Inhaled Gases)           |
|         |                                                                   |
|         v                                                                   |
|   DEFECTIVE RYR1 RECEPTOR (Massive Uncontrolled Sarcoplasmic Ca2+ Efflux)   |
|         |                                                                   |
|         +---------------------------------------+                           |
|         |                                       |                           |
|         v                                       v                           |
|   SUSTAINED MUSCLE CONTRACTION            MASSIVE HYPERMETABOLISM           |
|   - Masseter muscle spasm (jaw clench)    - Rapid, extreme rise in EtCO2    |
|   - Generalized muscular rigidity         - Profound metabolic acidosis     |
|         |                                 - Severe lactic acidemia          |
|         v                                 - Tachycardia & Arrhythmias       |
|   RHABDOMYOLYSIS & CELL LYSIS             - Late extreme Hyperthermia       |
|   - Massive Hyperkalemia (K+ > 7 mEq/L)     (Spikes up to 43°C / 109.4°F)   |
|   - Myoglobinuria (Tea-colored urine)                                       |
|   - Acute Tubular Necrosis (Renal failure)                                  |
+-----------------------------------------------------------------------------+

Triggering Agents vs. Safe Alternatives

• Known Triggers (Strictly Prohibited in MH Susceptible):
  • Depolarizing neuromuscular blocker: Succinylcholine (Anectine).
  • All volatile halogenated inhalation agents: Sevoflurane (Ultane), Desflurane (Suprane), Isoflurane (Forane), and historical agents (Halothane, Enflurane).
• Safe Non-Triggering Agents:
  • Intravenous hypnotics: Propofol, Etomidate, Ketamine, Barbiturates (Methohexital).
  • Opioids: Fentanyl, Sufentanil, Morphine, Hydromorphone, Remifentanil.
  • Non-depolarizing neuromuscular blockers: Rocuronium, Vecuronium, Cisatracurium.
  • Local anesthetics: All amides and esters (Lidocaine, Bupivacaine, Ropivacaine).
  • Nitrous Oxide ($N_2O$).

Clinical Manifestations in Chronological Sequence

1. Earliest and Most Sensitive Sign: Unexplained, rapid, progressive elevation of End-Tidal Carbon Dioxide ($EtCO_2$) that is completely refractory to aggressive hyperventilation.
2. Masseter Muscle Rigidity (MMR): Inability to open the patient's mouth ("jaws of steel") following succinylcholine administration.
3. Tachycardia & Tachypnea: Unexplained sinus tachycardia, tachypnea, unstable labile blood pressure, and ventricular arrhythmias (PVCs, ventricular tachycardia) driven by hyperkalemia.
4. Skin Changes: Sweating, cyanosis, and mottled skin.
5. Late, Ominous Sign: Extreme hyperpyrexia (hyperthermia), with body temperature rising at an alarming rate of 1°C to 2°C every 5 minutes, reaching lethal extremes up to 43°C (109.4°F).
6. Laboratory Derangements: Mixed respiratory and metabolic acidosis ($pH < 7.15$), severe hyperkalemia, elevated serum creatine kinase ($CK > 20,000\text{ IU/L}$), myoglobinemia, and dark brown/tea-colored urine (myoglobinuria).

MHAUS Emergency Treatment Protocol

Reconstitution of Dantrolene Formulations

• Classic Dantrolene (Dantrium / Revonto): Each vial contains $20\text{ mg}$ lyophilized Dantrolene and $3\text{ g}$ Mannitol. Must be reconstituted with $60\text{ mL}$ of sterile preservative-free water (never bacteriostatic water or saline). A typical adult patient requires 8 to 12 vials for the initial $2.5\text{ mg/kg}$ dose, requiring multiple personnel to shake vials vigorously.
• Ryanodex (Concentrated Dantrolene): Each vial contains $250\text{ mg}$ of nano-suspension Dantrolene. Reconstituted rapidly with only $5\text{ mL}$ of sterile water within 1 minute, delivering an entire therapeutic adult dose in a single syringe.

Role of the Certified Surgical Technologist During an MH Crisis

1. Maintain the Sterile Field: Immediately protect the wound and instruments; if the surgery is aborted, assist the surgeon with rapid temporary wound closure or packing.
2. Break Down Non-Essential Setup: Clear space around the operating table for the arriving resuscitation team and MH cart.
3. Provide Cold Sterile Irrigation: Deliver sterile cold saline to the surgical field if open cavitary lavage is performed by the surgeon.
4. Assist with Medication Reconstitution: If unscrubbed or delegated, assist in rapidly reconstituting multiple vials of Dantrolene with sterile water.
5. Monitor Counts: Ensure all sponges and instruments are tracked if rapid emergency packing or closure occurs.

---

2. Local Anesthetic Systemic Toxicity (LAST)

[!WARNING] Local Anesthetic Systemic Toxicity (LAST): A severe, potentially fatal complication resulting from inadvertent intravascular injection or massive systemic absorption of local anesthetics (most commonly Bupivacaine and Ropivacaine). Local anesthetics block voltage-gated sodium channels in the CNS and myocardium, causing progressive neuro-cardiovascular collapse.

Clinical Progression of LAST

• Initial CNS Excitation: Metallic taste in the mouth, circumoral numbness and tingling, tinnitus, visual disturbances, lightheadedness, agitation, and slurred speech.
• CNS Depression: Muscle twitching, tremors, generalized tonic-clonic seizures, followed by sudden unconsciousness, CNS depression, and apnea.
• Cardiovascular Collapse: Severe bradycardia, conduction heart blocks, ventricular tachycardia/fibrillation, profound hypotension, and asystole.

Treatment Protocol for LAST

1. Stop Injection Immediately: Discontinue local anesthetic administration.
2. Airway Management: Secure airway; hyperventilate with 100% Oxygen to prevent hypoxia, hypercapnia, and acidosis (which worsen toxicity).
3. Seizure Control: Administer IV Benzodiazepines (Midazolam).
4. Lipid Emulsion Rescue Therapy (20% Intralipid):
   • Mechanism: Acts as a "lipid sink", extracting lipophilic local anesthetics from plasma and myocardial tissue, and provides energetic substrate for the poisoned myocardium.
   • Dosing Protocol: Initial IV bolus of $1.5\text{ mL/kg}$ of 20% Intralipid over 1 minute -> continuous IV infusion of $0.25\text{ mL/kg/min}$ -> repeat bolus every 3–5 minutes if cardiovascular stability is not restored (max cumulative dose $12\text{ mL/kg}$).